Publication:
Retinal Arteriovenous Malformation in Wyburn-Mason Syndrome: A Rare Diagnostic Challenge Mimicking Central Retinal Vein Occlusion

dc.authorscopusid58998391900
dc.authorscopusid59205930300
dc.authorscopusid57192211319
dc.contributor.authorOzdemir, A.
dc.contributor.authorBodur, M.F.
dc.contributor.authorKocak, N.
dc.date.accessioned2025-12-11T01:43:20Z
dc.date.issued2025
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ozdemir] Ahmet, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bodur] Muhiddin Fatih, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kocak] Nurullah, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractWyburn-Mason syndrome (WMS) is a rare congenital disorder characterized by retinal and intracranial arteriovenous malformations (AVMs). These vascular anomalies can resemble central retinal vein occlusion (CRVO), potentially leading to misdiagnosis and inappropriate treatment. A 50-year-old female was initially misdiagnosed with CRVO and received intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Despite partial regression of macular edema, persistent vascular anomalies prompted multimodal imaging, confirming the diagnosis of WMS. Fundus examination revealed dilated, tortuous arteriovenous vessels extending from the optic disc, with macular exudation and a localized vitreous hemorrhage. Fluorescein angiography demonstrated early arteriovenous shunting without capillary nonperfusion, distinguishing it from CRVO. Optical coherence tomography (OCT) showed persistent cystoid macular edema without subretinal fluid. Systemic evaluation ruled out additional intracranial AVMs, apart from the patient’s known primary sclerosing cholangitis. Despite anti-VEGF therapy, macular edema only partially improved, and vision remained stable. This case underscores the importance of distinguishing WMS from CRVO through multimodal imaging and highlights the limited efficacy of anti-VEGF therapy in WMS-associated macular edema. Accurate differentiation between these conditions is essential for optimizing management and preventing unnecessary interventions. © © 2025 The author(s). This is an open-access article under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.en_US
dc.identifier.doi10.37845/ret.vit.2025.34.32
dc.identifier.endpage235en_US
dc.identifier.issn1300-1256
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-105017882581
dc.identifier.scopusqualityQ4
dc.identifier.startpage230en_US
dc.identifier.trdizinid1343501
dc.identifier.urihttps://doi.org/10.37845/ret.vit.2025.34.32
dc.identifier.urihttps://search.trdizin.gov.tr/en/yayin/detay/1343501/retinal-arteriovenous-malformation-in-wyburn-mason-syndrome-a-rare-diagnostic-challenge-mimicking-central-retinal-vein-occlusion
dc.identifier.urihttps://hdl.handle.net/20.500.12712/45494
dc.identifier.volume34en_US
dc.language.isoenen_US
dc.publisherGazi Eye Foundationen_US
dc.relation.ispartofRetina-Vitreusen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCentral Retinal Vein Occlusionen_US
dc.subjectFluorescein Angiographyen_US
dc.subjectRetinal Arteriovenous Malformationen_US
dc.subjectWyburn-Mason Syndromeen_US
dc.titleRetinal Arteriovenous Malformation in Wyburn-Mason Syndrome: A Rare Diagnostic Challenge Mimicking Central Retinal Vein Occlusionen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files